TP53 and colorectal carcinoma: The network analysis uncovered that HDW probably exerted its pharmacological effects on CRC via modulating certain targets, including HRAS, PIK3CA, KRAS, TP53, APC, BRAF, GSK3B, CDK2, AKT1, and RAF1.